Health Care • Biotechnology: Laboratory Analytical Instruments
$1,718.61 ▲ +20.14
(+1.19%)
MKT CAP: $34.44B • VOL: 129.6K
52W L $1,023 52W H $1,729
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$1,444
MEDIAN
$1,925
MEAN
$1,959
HIGH
$2,337
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE MTD TAPE
MTD // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $2,079.52 | $1,976.40 | 2025-02-14 | $1,563.94 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $2,165.45 | $2,027.96 | 2025-02-06 | $1,615.49 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $1,959.22 | $1,890.47 | 2025-01-29 | $1,649.87 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $1,752.98 | — | 2025-01-17 | $1,684.24 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $1,512.38 | $1,632.68 | 2025-01-09 | $1,529.56 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $2,045.15 | $1,787.35 | 2024-12-18 | $1,495.19 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $1,667.05 | $1,735.80 | 2024-12-04 | $1,598.31 | -4.3% | 48% | C |